developing News newsbot.ch

Wirtschaft »

Roche to present results of first prospective trial using blood-based next generation sequencing which successfully identifies people for treatment with Alecensa

2019-09-30 07:20:03


Wirtschaft »

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

2019-09-28 06:20:30


Inland »

Eröffnungszeremonie für das neue Generalkonsulat in Chicago (en)

2019-09-23 18:52:21


Wirtschaft »

Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress

2019-09-23 07:20:16


Wirtschaft »

Positive phase III results show Xofluza reduces risk of developing flu after contact with an infected person by 86%

2019-09-02 22:40:14


Wirtschaft »

Roche presents positive phase III study results for one-dose Xofluza in children with flu

2019-09-02 22:40:14


Wirtschaft »

FDA approves Roche’s Rozlytrek (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours

2019-08-16 16:40:40


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-07-31 09:24:45


Wirtschaft »

Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress

Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress

2019-07-09 09:20:15


Wirtschaft »

FDA grants Roche’s Polivy accelerated approval for people with previously treated aggressive lymphoma

2019-06-11 14:40:06


Wirtschaft »

Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-06-10 12:40:00


Wirtschaft »

Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine

2019-06-04 19:20:00


Wirtschaft »

Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia

Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia

2019-05-16 08:40:14


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-05-14 05:20:02


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-04-03 15:40:15


Wirtschaft »

FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer

2019-03-19 07:20:00


Wirtschaft »

European Commission approves Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors

2019-03-14 06:40:00


Wirtschaft »

Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash

2019-03-07 19:20:03


Wirtschaft »

Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions

2019-03-07 14:20:29


Wirtschaft »

Roche enters into definitive merger agreement to acquire Spark Therapeutics

2019-02-25 09:20:18



Suchresultate als RSS-Feed